Judging panel for ROAR Awards announced

In Orphan Drug Congress, Orphan Drugs Live by Georgia

The Rare & Orphan Advocacy & Research (ROAR) Awards are back for their 2nd year on 13 November in Brussels, in conjunction with the 5th annual World Orphan Drug Congress.

The 2014 ROAR Awards will recognise those who have done outstanding work in the field, honour those who have made significant contributions to the development of the sector, and celebrate the great achievements made in the world of orphan drugs in the last year. We would love for you to join us.

The award categories are open for nominations until 1 October 2014. After this the shortlist will be sent to our judging panel.

Categories are:

  • Outstanding Contract Research Campaign
  • Outstanding Market Access Campaign
  • Outstanding Innovation Award
  • Outstanding Patient Advocacy Award
  • Inspirational Stakeholder of the Year
  • 2014 European Leadership Award

Nominations come from the sector before being passed over to our Judging Panel, therefore please make your nominations at www.terrapinn.com/ROARAwards before 1 October to get your preferred organisations and people onto the shortlist.


Confirmed judges include:

Dr Geoffrey W Guy, Chairman and Founder, GW Pharmaceuticals plc

 Dr Anthony Hall, Co Founder, Findacure Foundation

Hans Schikan, CEO, Prosensa

 Ann-Teresa Cusenza, Medical Information Specialist, Managing Editor, Orphan Druganaut Blog

Dr Ségolène Aymé, Emeritus Research Director at INSERM , Project Leader of IRDiRC SUPPORT


Make sure your organisation, partners and clients make the shortlist – nominate today at www.terrapinn.com/ROARAwards.

The ROAR Awards and gala dinner are an exciting part of this industry-leading meeting. Book your place today at www.terrapinn.com/orphan-drugs.